Selective estrogen receptor modulators: tissue specificity and clinical utility
Selective estrogen receptor modulators (SERMs) are a diverse group of nonsteroidal
compounds that function as agonists or antagonists for estrogen receptors (ERs) in a target …
compounds that function as agonists or antagonists for estrogen receptors (ERs) in a target …
Molecular and pathologic aspects of endometrial carcinogenesis
JL Hecht, GL Mutter - Journal of clinical oncology, 2006 - ascopubs.org
Endometrial cancer is the most common gynecological malignancy, with 41,000 new cases
projected in the United States for 2006. Two different clinicopathologic subtypes are …
projected in the United States for 2006. Two different clinicopathologic subtypes are …
[HTML][HTML] Theories of endometrial carcinogenesis: a multidisciplinary approach
ME Sherman - Modern Pathology, 2000 - Elsevier
Historical observations have suggested that endometrial carcinomas vary in histopathologic
appearance and clinical features. More recent, systematic studies have provided …
appearance and clinical features. More recent, systematic studies have provided …
The frequency of p53, k‐ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: Evidence of distinct molecular genetic …
SF Lax, B Kendall, H Tashiro, RJC Slebos… - Cancer, 2000 - Wiley Online Library
BACKGROUND The two most common types of uterine endometrial carcinoma,
endometrioid (UEC) and serous (USC), differ in their histopathologic appearance and …
endometrioid (UEC) and serous (USC), differ in their histopathologic appearance and …
Oncogenic mutations in histologically normal endometrium: the new normal?
V Lac, TM Nazeran, B Tessier‐Cloutier… - The Journal of …, 2019 - Wiley Online Library
The advent of next generation sequencing has vastly improved the resolution of mutation
detection, thereby both increasing the resolution of the analysis of cancer tissues and …
detection, thereby both increasing the resolution of the analysis of cancer tissues and …
p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis
ME Sherman, ME Bur, RJ Kurman - Human pathology, 1995 - Elsevier
To elucidate the role of p53 abnormalities in endometrial tumorigenesis, a diverse group of
endometrial neoplasms and their putative precursors, atypical endometrial hyperplasia, and …
endometrial neoplasms and their putative precursors, atypical endometrial hyperplasia, and …
Molecular pathology of endometrial hyperplasia and carcinoma
X Matias-Guiu, L Catasus, E Bussaglia, H Lagarda… - Human pathology, 2001 - Elsevier
Four different genetic abnormalities may occur in endometrioid adenocarcinomas of the
endometrium (mircosatellite instability and mutations in the PTEN, k-RAS and β-catenin …
endometrium (mircosatellite instability and mutations in the PTEN, k-RAS and β-catenin …
Novel molecular profiles of endometrial cancer—new light through old windows
Endometrial carcinoma (EC) is the most common gynecological malignancy in the western
world. A widely accepted dualistic model, which has been established on a morphological …
world. A widely accepted dualistic model, which has been established on a morphological …
Targeting KRAS in Cancer: Promising Therapeutic Strategies
LM Mustachio, A Chelariu-Raicu, L Szekvolgyi… - Cancers, 2021 - mdpi.com
Simple Summary Since the Kirsten rat sarcoma viral oncogene homolog (KRAS) is mutated
in about 25% of all human cancers and is at the center of pathways involved in …
in about 25% of all human cancers and is at the center of pathways involved in …
Endometrial carcinoma: pathology and genetics
J Prat, A Gallardo, M Cuatrecasas, L Catasús - Pathology, 2007 - Taylor & Francis
In the Western world, endometrial carcinoma is the most common malignant tumour of the
female genital tract and the fourth most common cancer in women after carcinomas of …
female genital tract and the fourth most common cancer in women after carcinomas of …